Vetter Pharma-Fertigung Wins International Innovation Award
04-05-2007: Vetter Pharma-Fertigung GmbH & Co. KG was announced as the winner in the Process Innovation category of the third annual Facility of the Year Awards (FOYA). The contract manufacturer from Ravensburg, Germany was the only European company selected by the judging panel, recognising state-of-the-art pharmaceutical manufacturing projects that utilise new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high quality medicines.
Vetter was commended for its new facility, Ravensburg Vetter South, which took 36 months from start of detailed design to complete validation. Building on more than a quarter of a century of expertise in prefilling, the new production site maximises the use of automation and maintains the highest standards in terms of sterility, safety, and quality. The two filling lines feature brand new Restricted Access Barrier System (RABS), with plans for a further two lines in the near future.
The site, which was completed in October 2006 is completely self-sufficient with its own utility and power supply and has a capacity of 90 million units per year.
The FOYA are sponsored by the International Society for Pharmaceutical Engineering (ISPE), INTERPHEX and Pharmaceutical Processing magazine, and represent a cross-section of a global industry, with this year's winners spanning the US, Japan, China and Germany.
- Vetter
- validation
- ISPE
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- Roche Diagnostics and FIND sign agreement of collaboration in diagnostics for poverty-related diseases -
- CNS-Diagnostics: Chimera Biotec Starts Study on Novel Biomarker Detection for Alzheimer's Disease - - European Commission supports study including 11 centres from 6 European countries
- Worldwide standards for clinical proteome analyses - - The dream of individual medicine gets the scientific basis
- Graffinity and Amgen enter into drug discovery research agreement -
- 3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd. -





